BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 10892716)

  • 1. Cutaneous lymphoid hyperplasias.
    Gilliam AC; Wood GS
    Semin Cutan Med Surg; 2000 Jun; 19(2):133-41. PubMed ID: 10892716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous Pseudolymphomas.
    Romero-Pérez D; Blanes Martínez M; Encabo-Durán B
    Actas Dermosifiliogr; 2016 Oct; 107(8):640-51. PubMed ID: 27289134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous lymphoid hyperplasia and cutaneous marginal zone lymphoma: comparison of morphologic and immunophenotypic features.
    Baldassano MF; Bailey EM; Ferry JA; Harris NL; Duncan LM
    Am J Surg Pathol; 1999 Jan; 23(1):88-96. PubMed ID: 9888708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous pseudolymphomas.
    Ploysangam T; Breneman DL; Mutasim DF
    J Am Acad Dermatol; 1998 Jun; 38(6 Pt 1):877-95; quiz 896-7. PubMed ID: 9631994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous lymphoid hyperplasia: a case report and brief review of the literature.
    Lackey JN; Xia Y; Cho S; Sperling LC
    Cutis; 2007 Jun; 79(6):445-8. PubMed ID: 17713147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heavy multinodular cutaneous lymphoid infiltrates: clinicopathologic features and B-cell clonality.
    Ceballos KM; Gascoyne RD; Martinka M; Trotter MJ
    J Cutan Pathol; 2002 Mar; 29(3):159-67. PubMed ID: 11972713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous lymphoid hyperplasia: a lymphoproliferative continuum with lymphomatous potential.
    Nihal M; Mikkola D; Horvath N; Gilliam AC; Stevens SR; Spiro TP; Cooper KD; Wood GS
    Hum Pathol; 2003 Jun; 34(6):617-22. PubMed ID: 12827617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous lymphoid hyperplasia and other lymphoid infiltrates of the breast nipple: a retrospective clinicopathologic study of fifty-six patients.
    Boudova L; Kazakov DV; Sima R; Vanecek T; Torlakovic E; Lamovec J; Kutzner H; Szepe P; Plank L; Bouda J; Hes O; Mukensnabl P; Michal M
    Am J Dermatopathol; 2005 Oct; 27(5):375-86. PubMed ID: 16148405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-cell cutaneous lymphoid hyperplasia representing progressive transformation of germinal center: a report of 2 cases.
    Kojima M; Sakurai S; Shimizu K; Itoh H
    Int J Surg Pathol; 2010 Oct; 18(5):429-32. PubMed ID: 18815203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of 55 cases of cutaneous lymphoid hyperplasia: reassessment of the histopathologic findings leading to reclassification of 4 lesions as cutaneous marginal zone lymphoma and 19 as pseudolymphomatous folliculitis.
    Arai E; Shimizu M; Hirose T
    Hum Pathol; 2005 May; 36(5):505-11. PubMed ID: 15948117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of clonality of atypical cutaneous lymphoid infiltrates associated with drug therapy by PCR/DGGE.
    Brady SP; Magro CM; Diaz-Cano SJ; Wolfe HJ
    Hum Pathol; 1999 Feb; 30(2):130-6. PubMed ID: 10029439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous reactive B-cell lymphoid proliferations.
    Khalil S; Donthi D; Gru AA
    J Cutan Pathol; 2022 Oct; 49(10):898-916. PubMed ID: 35656820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphomatoid keratosis: an epidermotropic type of cutaneous lymphoid hyperplasia: clinicopathological, immunohistochemical, and molecular biological study of 6 cases.
    Arai E; Shimizu M; Tsuchida T; Izaki S; Ogawa F; Hirose T
    Arch Dermatol; 2007 Jan; 143(1):53-9. PubMed ID: 17224542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudoclonality in cutaneous pseudolymphomas: a pitfall in interpretation of rearrangement studies.
    Böer A; Tirumalae R; Bresch M; Falk TM
    Br J Dermatol; 2008 Aug; 159(2):394-402. PubMed ID: 18547309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cutaneous lymphoid hyperplasia (pseudolymphoma) on the red dye of a tattoo].
    Gardair Bouchy C; Kerdraon R; Kluger N; Armingaud P; Wakosa A; Estève E
    Ann Pathol; 2013 Aug; 33(4):273-7. PubMed ID: 23954123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Approach to dermal-based lymphoid infiltrates and proliferations.
    Charli-Joseph Y; Toussaint-Claire S; Lome-Maldonado C; Montante-Montes de Oca D; Ortiz-Hidalgo C
    Semin Cutan Med Surg; 2018 Mar; 37(1):61-74. PubMed ID: 29719022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell-rich angiomatoid polypoid pseudolymphoma of the skin: a clinicopathologic study of 17 cases and a proposed nomenclature.
    Dayrit JF; Wang WL; Goh SG; Ramdial PK; Lazar AJ; Calonje E
    J Cutan Pathol; 2011 Jun; 38(6):475-82. PubMed ID: 21352259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-evaluation of "reactive lymphoid hyperplasia of the uvea": an immunohistochemical and molecular analysis of 10 cases.
    Cockerham GC; Hidayat AA; Bijwaard KE; Sheng ZM
    Ophthalmology; 2000 Jan; 107(1):151-8. PubMed ID: 10647734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of histologic and immunophenotypical staining patterns in cutaneous lymphoid hyperplasia.
    Bergman R; Khamaysi K; Khamaysi Z; Ben Arie Y
    J Am Acad Dermatol; 2011 Jul; 65(1):112-24. PubMed ID: 21501893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD-1, S-100 and CD1a expression in pseudolymphomatous folliculitis, primary cutaneous marginal zone B-cell lymphoma (MALT lymphoma) and cutaneous lymphoid hyperplasia.
    Goyal A; Moore JB; Gimbel D; Carter JB; Kroshinsky D; Ferry JA; Harris NL; Duncan LM
    J Cutan Pathol; 2015 Jan; 42(1):6-15. PubMed ID: 25384543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.